Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Interest & Investment Income (2016 - 2025)

Surgery Partners' Interest & Investment Income history spans 12 years, with the latest figure at -$67.6 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 27.79% year-over-year to -$67.6 million; the TTM value through Dec 2025 reached -$272.6 million, down 35.15%, while the annual FY2025 figure was -$272.6 million, 35.15% down from the prior year.
  • Interest & Investment Income for Q4 2025 was -$67.6 million at Surgery Partners, up from -$74.9 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at -$46.8 million in Q1 2023 and bottomed at -$74.9 million in Q3 2025.
  • The 5-year median for Interest & Investment Income is -$53.8 million (2021), against an average of -$56.2 million.
  • The largest annual shift saw Interest & Investment Income increased 20.16% in 2023 before it plummeted 49.8% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at -$60.1 million in 2021, then decreased by 1.5% to -$61.0 million in 2022, then grew by 20.16% to -$48.7 million in 2023, then fell by 8.62% to -$52.9 million in 2024, then decreased by 27.79% to -$67.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Interest & Investment Income are -$67.6 million (Q4 2025), -$74.9 million (Q3 2025), and -$67.9 million (Q2 2025).